ArticleClinical rheumatology2017

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Florenzo Iannone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.